Global review of COVID-19 mitigation strategies and their impact on cancer service disruptions
Richa Shah(Centre international de recherche sur le cancer), Isabelle Soerjomataram(Centre international de recherche sur le cancer), Hanna Fink(Centre international de recherche sur le cancer), Richard Sullivan(King's College London), Ethna McFerran(Queen's University Belfast), Suryakanta Acharya, Jonathan Cylus(London School of Economics and Political Science), Michael David(Griffith University), Ching Ee Loo(Ministry of Health), Montse García(Institut d'Investigació Biomédica de Bellvitge), Freddie Bray(Centre International de Recherche sur le Cancer), Karen Chiam(Hanson Institute), Suzanne Hughes(The University of Sydney), Julia Steinberg(Centre for Human Genetics), Jean Niyigaba(Centre international de recherche sur le cancer), Michael Caruana(The University of Sydney), André Ilbawi, Harriet Hui(The University of Sydney), Ophira Ginsburg(National Cancer Institute), Oliver Langselius(Centre international de recherche sur le cancer), Nader Mounir Hanna(Queen's University), Nwamaka Lasebikan(University of Nigeria Teaching Hospital), Clara Frick(German Cancer Research Center), Karen Canfell(The University of Sydney)
Cited by 4
Related Papers
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
|CA A Cancer Journal for Clinicians|2024|22.1k
Global Cancer Statistics, 2002
|CA A Cancer Journal for Clinicians|2005|18.4k
Estimating the world cancer burden: Globocan 2000
|International Journal of Cancer|2001|3.7k
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
|The Lancet Global Health|2019|2.4k
Estimates of the worldwide mortality from 25 cancers in 1990
|International Journal of Cancer|1999|1.5k